The structure of a reduced mutant T4 glutaredoxin  by Ingelman, Margareta et al.
FEBS 15878 FEBS Letters 370 (1995) 209 211 
The structure of a reduced mutant T4 glutaredoxin 
Margareta Ingelman, Par Nordlund**, Hans Eklund* 
Department of Molecular Biology, Swedish University of Agricultural Sciences, Biomedical Center, Box 590, S-751 24 Uppsala, Sweden 
Received 29 June 1995; revised version received 10 July 1995 
Abstract The mutant T4 glutaredoxin where the active site res- 
idues Val TM and Tyr 16 have been substituted by Gly and Pro, 
respectively, crystallizes in a form where the active site disulfide 
is accessible to reagents. Treatment of the crystals with dithiotre- 
itol causes very subtle changes in the overall glntaredoxin struc- 
ture. The main differences are seen around the active site where 
the sulfurs of Cys 14 and Cys 17 move apart slightly. 
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1. Introduction 
Ribonucleotide r ductase, a key enzyme in DNA synthesis, 
is responsible for the de novo synthesis of the necessary deoxy- 
ribonucleotides. In this reaction, thiol groups of the enzyme are 
oxidized to form a disulfide bridge which has to be reduced for 
the next catalytic ycle. There are at least two systems in cells 
which are able to reduce ribonucleotide r ductase: the thiore- 
doxin and glutaredoxin systems [1]. Thioredoxins and glutare- 
doxins are small ct/fl proteins with redox active thiols. Both 
systems use NADPH-dependent flavoproteins for the regenera- 
tion of reduced thioredoxin and glutaredoxin. Thioredoxin is 
reduced by thioredoxin reductase while glutaredoxin s reduced 
by glutathione, which has previously been reduced by glutathi- 
one reductase. 
When bacteriophage T4 infects Escherichia coli, a bacterio- 
phage ncoded ribonucleotide r ductase and a glutaredoxin are 
synthesized for the production of bacteriophage DNA. This T4 
glutaredoxin can use both reducing systems for its regenera- 
tion. It was originally called T4 thioredoxin since it is reduced 
by thioredoxin reductase, but sequence comparisons clearly 
show that the T4 protein belongs to the glutaredoxin family [2]. 
The three-dimensional structure of T4 glutaredoxin has a 
central pleated sheet with both parallel and antiparallel strands 
surrounded by helices [3,4]. E. coli glutaredoxin [5] and thiore- 
doxin [6,7] as well as human thioredoxin [8], have structures 
similar to T4 glutaredoxin except hat the thioredoxins have an 
additional t-strand and or-helix at their N-terminus. The active 
site disulfide is located at equivalent positions at the amino-end 
of the longest helix in all these proteins. 
All crystallographic investigations of thioredoxins and glu- 
taredoxins have so far been performed on oxidized disulfide 
forms of the proteins. Direct reduction of the crystals has not 
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been possible since both E. coli thioredoxin and T4 glutare- 
doxin were crystallized with help of metal ions which link mol- 
ecules together in layers. All attempts to reduce these crystal- 
lized proteins resulted in destruction of the crystals ince the 
metals are reduced and/or emoved. 
NMR investigations have recently given a detailed picture of 
what happens when the human and E. coli thioredoxins are 
reduced [8,9]. The overall structures of the reduced thioredox- 
ins are similar to those of oxidized thioredoxins, but differ in 
the local conformation of the active site cysteines. In the E. coli 
thioredoxin, the side chain sulfur atom of Cys 32 is tilted away 
from that of Cys 35 in the reduced form [9]. In human thiore- 
doxin, Cys 35 is turned away in the reduced form, while Cys 32 
remains in a similar position in the two forms [8]. Residues 9-12 
in the active site of oxidized E. coli glutaredoxin s part of a 
locally disordered region which makes the detailed comparison 
of the residues at the active site difficult [10]. 
In order to investigate he role of the active site residues of 
T4 glutaredoxin, a series of mutant proteins were produced 
[2,11,12]. The double mutant Va115---~ Gly and TyrO6---) Pro crys- 
tallized in a new crystal form. These crystals diffract much 
better than the wild-type crystals which made possible a struc- 
ture determination to higher esolution (1.45 A) [4]. The mutant 
was crystallized in the absence of metals, in contrast o wild- 
type crystals which were obtained in presence of cadmium. This 
has now given us a possibility to obtain reduced crystalline 
glutaredoxin. In these orthorhombic crystals, the main crystal 
interaction is formed between the amino end of the last helix 
and the carboxyl end of the same helix in another molecule [4]. 
The crystal packing leaves the active site accessible for reagents. 
We here report the differences between the reduced and oxi- 
dized mutant glutaredoxin determined from crystallographic 
investigations of this crystal form. 
2. Experimental 
The isolation of the glutaredoxin gene, mutagenesis and overproduc- 
tion of the mutant protein have been described by Joelson et al. [11]. 
Crystals were obtained by the hanging drop method using 50 mM MES 
buffer, pH 6.5, and 5% PEG 4000 as precipitant. The crystals are 
orthorhombic P212121 with cell dimensions a = 30.2/~, b= 47.8 ,~ and 
c = 61.3 A and with one molecule in the asymmetric unit. The structure 
of the mutant protein was solved by molecular replacement methods 
and has been refined to an R-value of 17.5% at 1.45 A resolution [4]. 
Crystals were reduced by soaking in 50 mM dithiotreitol in 50 mM 
MES, pH 6.0, for 2 h. A data-set was collected on one crystal using a 
Xentronics area detector (Nicolet) mounted on a Rigaku rotating 
anode. The data was evaluated using the BUDDHA program [13]. The 
obtained ata-set extends to 2.4 A resolution and contains 80% of all 
possible reflections tothis resolution. The dataset was scaled using the 
CCP4 programs (Daresbury, UK). The internal Rsy m for symmetry 
related reflections was 5.4%. The data set from the reduced crystals 
scaled to a dataset of the oxidized glutaredoxin mutant with 10.2% 
differences inFs. 
The structure was refined with the XPLOR program [14] using pos- 
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itional and temperature factor refinement. The starting coordinates 
were from the refined oxidized glutaredoxin [4]. In this model the active 
site cysteines were changed according to the Fred-Fox difference Fourier 
map before refinement. The final R-value for the refinement of the 
reduced glutaredoxin mutant is 14.3% for the reflections between 7.0 
and 2.4 A. 
3. Results 
The Frea-Fo~ difference Fourier map shows two large nega- 
tive peaks, a few smaller negative peaks and a few positive 
peaks (Fig. 1). As expected, one of the major negative peaks 
occur at the place of the former disulfide bridge with the largest 
positive peak outside the sulfur atom of Cys 14 indicating that 
the side chain of this residue has turned outward towards the 
solvent. A small positive density beside the sulfur atom of Cys 17 
indicate that the cysteine residue has turned slightly inward. 
There was also small negative density on the main chain of 
Gly ~5 and Pro 16 suggesting a small displacement of these resi- 
dues or higher mobility. Small positive-negative peaks around 
Phe 33 and Lys 2~ show that these residues close to the active site 
also experience small positional shifts. Met ~ and Met 37 also 
have small positive densities. 
One of the largest negative peaks in the difference Fourier 
map was located outside the protein. After analysis of the 
corresponding position in the oxidized T4 glutaredoxin we in- 
terpreted it to be the sulfate part of a MES buffer molecule (Fig. 
2). In the refined map of the oxidized glutaredoxin the density 
corresponding to the sulfate is clear and one of the oxygen 
atoms makes hydrogen bonds to the main chain nitrogen of 
residue 64, to the OH group of the side chain of Tyr 7 and a 
water molecule [4]. This molecule is bound about 6 A from the 
disulfide bridge of the active site. 
The refined structure of the reduced glutaredoxin confirms 
the observations made from the difference Fourier map. The 
overall structure is little affected by the reduction and the root 
mean square difference for all atoms is only 0.1 A. The only 
change larger than 0.5 A is found for the $7 atom of Cys 14 
which differs by 0.6 A in the two structures (Fig. 3). 
4. Discussion 
Our experiment shows that mutant T4 glutaredoxin can be 
reduced in the crystalline state. The amount of remaining oxi- 
dized glutaredoxin molecules i very small as judged from the 
height of the difference lectron density maps calculated from 
the reduced protein at the end of the refinement and the oxi- 
dized protein at the start. 
The T4 glutaredoxin accommodates the breaking of the di- 
sulfide bridge by moving the exposed sulfur atom away from 
the other and keeping the internal cysteine side chain approxi- 
mately in the same place as in the oxidized form. The limited 
conformational changes eem to be compatible with reduction 
of E. coli glutaredoxin as investigated by NMR methods [10]. 
Similar types of conformational changes take place in both 
human and E. coli thioredoxins and in glutathione reductase 
when their active site disulfide bridge is reduced [8,9,15]. 
The reason why the MES buffer molecule does not bind to 
the reduced form of glutaredoxin may be that the negative 
charge of the reduced Cys 14 repels the negative charged sulfate 
of the buffer molecule. The pKa of the cysteine residues has not 
been determined but investigations onthe E. coli glutaredoxin 
indicate that the pK a of the corresponding residue is lower than 
5 [17,18]. Similarly, the corresponding residue in a mammalian 
glutaredoxin has been suggested to have a pKa of 2.5 [19]. For 
the E. coli thioredoxin the corresponding residue has a pKa 
value of 6.7 [20]. 
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Fig. 1. (A, top left) Difference Fourier (IFr~dl-IFox 1) contoured at a + 30" level for the part corresponding to one glutaredoxin molecule. Positive 
densities are magenta and negative densities are white. The cysteines are located in the middle of the bottom of the picture with the MES molecule 
at the bottom right. (B, top right) The part corresponding to the active site area with the cysteines tothe left and the MES molecule to the right. 
Fig. 2. The position where a MES buffer molecule was interpreted inthe electron density map of oxidized crystals. (Positively contoured map at the 
1 a level). 
Fig. 3. The final model of the active site of reduced glutaredoxin after efinement with the corresponding part of the oxidized glutaredoxin. The main 
difference is that the cysteine sulfur atoms move apart upon reduction. 
